The research about cancer patients quality of life on before and after therapy of high emetogenic cytotostatic in RSUP Dr. Sardjito Yogyakarta by EORTC QLQ_C30 has been done. This research used cohort design with cancer patients who just the first time received cisplatin ≥ 50 mg/m2 and or its combination, and alsogot ondansetron-dexamethasone as anti-emetics. While the patients were given EOR…